The federal contract IDV awarded to Verrica Pharmaceuticals Inc. is a Federal Supply Schedule (FSS) contract under Schedule 65 IB, with a ceiling value of $25,000 and a period of performance through February 2024. The contract, awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 12, is for pharmaceutical products including drugs, pharmaceuticals, and hematology-related items. Verrica Pharmaceuticals also holds a $1.25M Blanket Purchase Agreement (BPA) with...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Verrica Pharmaceuticals Inc., a for-profit pharmaceutical company. The single-award BPA has a ceiling value of $1,250,000 and a period of performance from September 2, 2023 to August 13, 2024. The BPA is for the pharmaceutical product YCANTH, which Verrica Pharmaceuticals supplies to the VA through this contract vehicle as well as other Federal Supply Schedule (FSS)...
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Verrica Pharmaceuticals Inc. The single-award BPA has a ceiling value of $1,250,000 and a period of performance from August 2024 to August 2026. The BPA is for the pharmaceutical product YCANTH, which appears to be a dermatology or hematology-related drug. Verrica Pharmaceuticals holds multiple contract vehicles with the VA, including a Federal Supply Schedule (FSS)...
The Federal Supply Schedule (FSS) contract awarded to Fera Pharmaceuticals, LLC is for the procurement of pharmaceutical drugs, pharmaceuticals, and hematology-related products. The prime contractor, Fera Pharmaceuticals, is a woman-owned small business that supplies the Department of Veterans Affairs (VA) and other government agencies with these products. The FSS contract, valued at up to $450,000.00, was awarded by the VA's Veterans Health Administration Veterans Integrated Service Network...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a Federal Supply Schedule (FSS) contract to Vistapharm, Inc., a for-profit manufacturer of pharmaceutical goods. The contract, with a potential value of $20,359,397, is under the VA's Veterans Integrated Service Network 12 and is part of the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract has a period of performance from September 30, 2017, to March 31, 2024, and does not utilize any...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Mycovia Pharmaceuticals, Inc. The contract is for Drugs, Pharmaceuticals, & Hematology Related Products under FSS Schedule 65 I B. The contract has a ceiling value of $25,000.00 and a period of performance through March 14, 2023. This is a multiple award, non-set-aside contract. The contract aims to procure pharmaceutical and hematology-related...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Acerus Pharmaceuticals Corporation. The contract, valued up to $750,000.00, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from May 15, 2021, to May 14, 2026. As an FSS contract, this is a multiple-award vehicle that provides federal agencies with a streamlined purchasing process to...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Verona Pharma, Inc. for the provision of pharmaceutical, hematology, and related products. The Multiple Award contract has a ceiling value of $225,000.00 and a period of performance from March 15, 2025 through March 14, 2030. The contract is classified as 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS under the Federal Supply Schedule. As a Federal Supply Schedule, this is an...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Arcutis Biotherapeutics, Inc., a for-profit manufacturer. The contract has a ceiling value of $7,000,000.00 and a period of performance that expires on January 14, 2028. The contract is for the delivery of "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS" under the FSS contract number 65 I B. The scope of the contract includes the...
The Federal Supply Schedule contract award is for Drugs, Pharmaceuticals, & Hematology Related Products (FSS Contract 65 I B) to Biofrontera Inc., a for-profit organization located in Woburn, MA. The contract has a period of performance from June 15, 2024 to June 15, 2029, with a ceiling value of $225,000.00. This multiple award contract was issued by the Veterans Integrated Service Network 12, a civilian agency. The contract aims to procure pharmaceuticals and related products for the...